Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

SAFTEE: a technique for the systematic assessment of side effects in clinical trials.

Levine J, Schooler NR.

Psychopharmacol Bull. 1986;22(2):343-81. No abstract available.

PMID:
3774930
2.

Reliability and validity of SAFTEE: preliminar analyses.

Guy W, Wilson WH, Brooking B, Manov G, Fjetland O.

Psychopharmacol Bull. 1986;22(2):397-401. No abstract available.

PMID:
3774933
3.

Side effect assessment with SAFTEE: pilot study of the instrument.

Rabkin JG, Markowitz JS.

Psychopharmacol Bull. 1986;22(2):389-96. No abstract available.

PMID:
3774932
4.

Interrater agreement and reliability measures of SAFTEE: general inquiry vs. systematic inquiry.

Jacobson AF, Goldstein BJ, Dominguez RA, Steinbook RM.

Psychopharmacol Bull. 1987;23(1):97-101. No abstract available.

PMID:
3299447
5.

Interrater agreement and intraclass reliability measures of SAFTEE in psychopharmacologic clinical trials.

Jacobson AF, Goldstein BJ, Dominguez RA, Steinbook RM.

Psychopharmacol Bull. 1986;22(2):382-8. No abstract available.

PMID:
3774931
6.

General versus systematic inquiry about emergent clinical events with SAFTEE: implications for clinical research.

Rabkin JG, Markowitz JS, Ocepek-Welikson K, Wager SS.

J Clin Psychopharmacol. 1992 Feb;12(1):3-10.

PMID:
1552037
7.

Intra-interrater reliability of SAFTEE using videotape interviews and clinical trial data.

Guy W, Wilson WH, Brooking B, Fjetland OK.

Psychopharmacol Bull. 1987;23(1):93-6. No abstract available.

PMID:
3299446
8.

Ascertainment of side effects in psychopharmacologic clinical trials.

Levine J.

Psychopharmacol Ser. 1990;8:130-5. Review. No abstract available.

PMID:
2198560
9.

SAFTEE: data system for side effect assessment scale.

Clyde DJ.

Psychopharmacol Bull. 1986;22(1):287. No abstract available.

PMID:
3726074
10.

Assessment of safety in pediatric psychopharmacology.

Greenhill LL.

J Am Acad Child Adolesc Psychiatry. 2003 Jun;42(6):625-6. No abstract available.

PMID:
12921468
11.

Use of statistics in the analysis of side effect data from clinical trials of psychoactive agents.

Assenzo JR, Shu VS.

Prog Neuropsychopharmacol Biol Psychiatry. 1982;6(4-6):543-50.

PMID:
6131489
12.

Guidelines for the evaluation of drugs in the elderly neuropsychiatric patients (demented and non-demented).

[No authors listed]

Pharmacopsychiatria. 1981 Sep;14(5):190-9. No abstract available.

PMID:
7291302
13.

Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs.

Leipzig RM, Cumming RG, Tinetti ME.

J Am Geriatr Soc. 1999 Jan;47(1):30-9.

PMID:
9920227
14.

Patient assessment in clinical trials.

Guy W.

Prog Neuropsychopharmacol Biol Psychiatry. 1982;6(4-6):601-6. No abstract available.

PMID:
6761766
15.

Drug monitoring in psychiatry.

Müller-Oerlinghausen B, Schmidt L, Rüther E.

Mod Probl Pharmacopsychiatry. 1981;16:101-8. No abstract available.

PMID:
7322129
16.

Psychotropic effects of antiepileptic drugs.

Boylan LS.

Neurology. 2007 Oct 16;69(16):1640; author reply 1640. No abstract available.

PMID:
17938375
17.

Number needed to harm.

Safer DJ, Zito JM.

J Nerv Ment Dis. 2013 Nov;201(11):1003. doi: 10.1097/NMD.0000000000000045. No abstract available.

PMID:
24177491
18.

Side effects data analysis.

Lavori PW.

Psychopharmacol Bull. 1986;22(2):402-4. No abstract available.

PMID:
3774934
19.

[Methodologic aspects in psychopharmacology].

Kaumeier HS.

Methods Find Exp Clin Pharmacol. 1982;4(7):539-42. German.

PMID:
6763118
20.

Number needed to harm can be clinically useful: a response to Safer and Zito.

Citrome L, Ketter TA.

J Nerv Ment Dis. 2013 Nov;201(11):1001-2. doi: 10.1097/NMD.0000000000000042. No abstract available.

PMID:
24177490

Supplemental Content

Support Center